Cardiogeni PLC – £650,000 Placing at 17.3p per share

by ollie@ojtdigital.com | May 22, 2025 | Uncategorized

Cardiogeni PLC – £650,000 Placing at 17.3p per share RNS Number : 6794J Cardiogeni PLC 22 May 2025 This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU...

Cardiogeni PLC – Formation of UAE joint venture company

by ollie@ojtdigital.com | May 6, 2025 | Uncategorized

Cardiogeni PLC – Formation of UAE joint venture company RNS Number : 6505L Cardiogeni PLC 05 June 2025 5th June 2025 Cardiogeni PLC (“Cardiogeni” or the “Company”) Formation of UAE joint venture company Cardiogeni (AQSE: CGNI),...

Cardiogeni PLC – Update on JV including £20m Funding

by ollie@ojtdigital.com | Apr 1, 2025 | Uncategorized

Cardiogeni PLC – Update on JV including £20m Funding RNS Number : 0284D Cardiogeni PLC 01 April 2025 April 1st 2025 Cardiogeni PLC (“Cardiogeni” or the “Company”) Update On The Joint Venture Including £20M Funding For The...

Cardiogeni PLC – Director’s Dealings

by ollie@ojtdigital.com | Feb 28, 2025 | Uncategorized

Cardiogeni PLC – Director’s Dealings RNS Number : 7920Y Cardiogeni PLC 28 February 2025 28 February 2025 Cardiogeni PLC (“Cardiogeni” or the “Company”) Director’s Dealings Cardiogeni (AQSE: CGNI), a UK clinical stage...

Cardiogeni PLC – £20M MoU for Funding Clinical Development in UAE

by ollie@ojtdigital.com | Feb 10, 2025 | Uncategorized

Cardiogeni PLC – £20M MoU for Funding Clinical Development in UAE RNS Number : 4929W Cardiogeni PLC 10 February 2025 10th February 2025 Cardiogeni PLC (“Cardiogeni” or the “Company”) Signing of Memorandum of Understanding with...

Cardiogeni PLC – Admission on AQSE and First Day of Dealings

by ollie@ojtdigital.com | Jan 31, 2025 | Uncategorized

Cardiogeni PLC – Admission on AQSE and First Day of Dealings RNS Number : 3634V Cardiogeni PLC 31 January 2025 31 January...